The NIH funded research into 'the world's second person known to have extreme resilience to a rare genetic form of early onset Alzheimer's disease', uncovering a gene related to Reelin protein production that may counterbalance Alzheimer's effects on the brain.
Multiple studies suggest Reelin can protect the brain from Alzheimer's and other aging diseases, hinting at potential future Alzheimer's treatments targeting the Reelin pathway.
Dr. Tabak emphasizes the importance of studying the Reelin pathway and brain region for developing Alzheimer's treatments, indicating a potential for drugs to enhance Reelin production or effects to combat the disease.
[
Collection
]
[
|
...
]